Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sanofi's Admelog, a Humalog Follow-On, Approved In US As 'Black Hole' For Insulins Looms

Dec 11 2017

• By Sue Sutter

Diabetes

Related Content

FDA Biologic Transition Plan Creates 'Dead Zone' For Applications, Sponsors Fear

May 23 2016

FDA Makes It Official With Basaglar Approval For Diabetes

Dec 16 2015

Insulin Exclusivity: How Big Will The Fight Be?

Mar 21 2016

BLAs More Appealing As 'Transition' NDAs, ANDAs Set To Lose Exclusivity

Mar 21 2016

FDA Endocrinology Division To Be Led By Thanh Hai On Interim Basis; Guettier Leaving For Private Sector

Dec 08 2017

All Set For EU Approval: First Biosimilar Humalog And Three More Rituximabs From Celltrion

May 19 2017

Insulin Market Competition: Payers Watching FDA 'Transition' Policy

Jul 07 2017

Related Companies

Sanofi

Eli Lilly and Company

Boehringer Ingelheim GmbH

Express Scripts Holding Company

Additional Topics

United States Approvals Biologics Review Pathway Regulation Metabolic Disorders BioPharmaceutical

More from Approvals

More from Product Reviews

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window